Am J Ophthalmol. 1996 Oct. 1224:590-1. Fluocinolone acetonide sustained drug delivery device for chronic central retinal vein occlusion: 12-month results. In about 10% of those affected, this loss of vision is preceded by one or more episodes of a condition called amaurosis fugal. Conclusion: The whole idea of surgical decompression of central retinal vein in CRTO is ill-conceived and based on lack of basic understanding of: a anatomy of the optic nerve and CRV and their relationship with each other, b the site of thrombosis in central retinal vein, and c the fact that a vein completely closed by a thrombus cannot be opened by “decompression” because the thrombus organizes shortly after it is formed see above. funds picture of a well-compensated, old central retinal vein occlusion showing optociliary shunt vessels. Ophthalmology In Press Weiss J, Bynoe LA: Injection of tissue plasminogen activator into a branch retinal vein in eyes with central retinal vein occlusion. For eye occlusion, you may receive ocular massage or glaucoma medications to lower eye pressure. Interventions for central retinal vein occlusion: an evidence-based systematic review. A carotid ultrasound duplex scan to determine whether there are carotid plaques present.
Diet should be tailored to systemic medical problems. The universal impression that cyclocryotherapy invariably results in phthisis bulb is based on aggressive 360o application at one sitting. Indian J Ophthalmol 1994;42:109-32.